| Cabotegravir Containing Agents - PA, NF |
Cabenuva (cabotegravir and rilpivirine) Injection, Vocabria (cabotegravir) Tablet |
| Calquence (acalabrutinib) |
Calquence (acalabrutinib) |
| Camzyos (mavacamten) - PA, NF |
Camzyos (mavacamten) |
| Cannabinoids |
Marinol (dronabinol) capsule, Syndros (dronabinol) oral solution |
| Caprelsa (vandetanib) |
Caprelsa (vandetanib) |
| Carbaglu (carglumic acid) |
Carbaglu (carglumic acid) tablets for oral suspension |
| Casgevy (exagamglogene autotemcel injection) |
Casgevy (exagamglogene autotemcel injection) |
| Cayston (aztreonam for inhalation solution) - PA, NF |
Cayston (aztreonam for inhalation solution) |
| Cequa (cyclosporine 0.09%) |
Cequa (cyclosporine 0.09%) ophthalmic solution |
| CGRP Inhibitors - PA, NF |
Aimovig (erenumab-aooe), Vyepti (eptinezumab-jjmr); Qulipta (atogepant), Ajovy (fremanezumab-vfrm), Emgality (galcanezumab-gnlm), Nurtec ODT (rimegepant), Ubrelvy (ubrogepant), Zavzpret (zavegepant) |
| Chenodiol Products |
Chenodal (chenodiol), Ctexli (chenodiol) |
| Cholbam (cholic acid) |
Cholbam (cholic acid) |
| Cibinqo (abrocitinib) |
Cibinqo (abrocitinib) |
| Cimzia (certolizumab pegol) |
Cimzia (certolizumab pegol) |
| Cinqair (reslizumab) |
Cinqair (reslizumab) |
| Ciprofloxacin-Containing Otic Agents |
Cetraxal (ciprofloxacin otic solution) |
| Cobenfy (xanomeline and trospium chloride) |
Cobenfy (xanomeline and trospium chloride) |
| Colony-Stimulating Factors (CSFs) - PA, NF |
Fulphila (pegfilgrastim-jmdb, G-CSF), Fylnetra (pegfilgrastim-pbbk), Nyvepria (pegfilgrastim-apgf, G-CSF), Stimufend (pegfilgrastim-fpgk), Ziextenzo (pegfilgrastim-bmez, G-CSF), Granix (tbo-filgrastim, G-CSF), Leukine (sargramostim, GM-CSF), Neulasta, Neulasta Onpro (pegfilgrastim, G-CSF), Neupogen (filgrastim, G-CSF), Nypozi (filgrastim-txid), Nivestym (filgrastim-aafi, G-CSF), Zarxio (filgrastim-sndz, G-CSF), Releuko (filgrastim-ayow), Rolvedon (eflapegrastim-xnst), Ryzneuta (efbemalenograstim alfa-vuxw), Udenyca (pegfilgrastim-cbqv, G-CSF) |
| Cometriq (cabozantinib) |
Cometriq (cabozantinib) |
| Commercial MEDLIMIT CDUR Criteria |
cumulative, MED, MEE, morphine, opioid |
HEALTHY LIVING